The global coronary stents market achieved revenue worth USD 8.4 Bn in 2026.
North America is anticipated to hold the largest market share in the market.
The primary factor projected to drive the coronary stents market expansion is continuous innovation that enhances stent biocompatibility, reduces complications and improving patient outcomes.
In 2025, cobalt chromium held a significant share of the global market.
The drug-eluting stent segment constitutes a major share of the market.